|Continuum Health Partners: Beth Israel • Roosevelt Hospital and St. Luke's Hospital • Long Island College Hospital • New York Eye and Ear Infirmary|
|Home | Find A Doctor | Contact Us|
A Phase III Randomized Study of Oral Sapacitabine In Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia
The primary objective of this study is to compare the overall survival
between those randomized to the group receiving sapacitabine and decitabine,
versus those receiving decitabine alone.
Please call for more information.
Copyright © 2008